查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1775452

全球动物感染疾病诊断市场：2025年至2030年预测

Global Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

动物感染疾病诊断市场预计将从 2025 年的 27.95 亿美元成长到 2030 年的 41.24 亿美元，复合年增长率为 8.09%。

感染疾病率上升

伴侣动物和牲畜感染疾病率的上升是市场扩张的主要驱动力。其中包括狂犬病在内的人畜共患疾病每年导致数万人死亡（根据世界卫生组织统计，99% 的人类感染疾病与狗有关）和通用，由于动物环境中不良的卫生习惯加剧了细菌、病毒和寄生虫感染而呈上升趋势。例如，狂犬病在 150 多个国家流行，每年造成经济约 86 亿美元的损失，亚洲和非洲受到的影响最大。通用易受疾病感染，五分之一的牲畜死于严重感染疾病，造成全球整体约 800 亿美元的经济损失。这凸显了定期诊断检测对于确保牲畜健康和防止疾病传播的重要性，特别是对于构成公共卫生风险的人畜共通感染疾病。禽流感等疾病进一步加剧了早期发现的迫切性，2023 年全球报告的疫情超过 3,500 起。

对动物健康的需求不断增加

牲畜对粮食安全、营养和经济成长至关重要，但感染疾病威胁牲畜生产力以及肉类、家禽和乳製品等畜产品的品质。不卫生的环境，例如受污染的水源和饲料，会滋生细菌和寄生虫，加剧疾病的传播。这导致对兽医诊断的需求日益增长，以降低风险并确保牲畜健康，这对于维持农业经济和满足全球粮食需求至关重要。

技术进步

诊断技术的进步正在改变市场，使疾病检测更快、更准确。 2024 年 9 月，硕腾推出了 Vetscan OptiCell，这是一款基于人工智慧的墨盒式血液学分析仪，用于即时全血细胞计数 (CBC) 分析。此外，硕腾还推出了 Stablelab，这是一款手持式照护现场血液检测仪，可在 10 分钟内透过血清淀粉样蛋白 A (SAA) 水平检测马匹的炎症，使兽医能够在症状出现之前识别感染疾病。 ProSolit 的牛病毒 3 血清学诊断 ELISA套件可快速可靠地检测牛血浆、血浆和牛奶，提高牲畜的诊断准确性。 2024 年 2 月，MiDOG Animal Diagnostics 推出了一种一体化诊断测试，可快速检测多种动物的细菌和真菌感染疾病（包括抗生素抗药性），以基于分子的诊断方法取代传统方法。这些技术创新反映了照护现场和分子诊断的趋势，推动了治疗效果的改善和市场的成长。

市场区隔分析

分子诊断

分子诊断领域预计将实现显着增长，这得益于其高灵敏度、快速结果以及在研究中心和诊断实验室的日益普及。即时PCR和多重PCR等技术，如硕腾VetScan Flex4等产品，能够准确检测感染疾病、遗传性疾病和基因组突变，进而监测治疗效果。牲畜和伴侣动物疾病的复杂性和流行程度日益增加，促使饲主选择这些先进的检测方法，从而在预测期内提升市场占有率。

农场动物

由于感染疾病的高疾病负担和经济影响，畜牧业预计将占据显着的市场占有率。定期诊断监测牛结核病、猪瘟和禽流感等疾病对于维护牛健康和确保食品安全至关重要。例如，在硕腾公司于2023年8月推出的Vetscan Mastigram+的支援下，定期对乳牛进行乳房炎筛检，有助于提高牛奶品质和牛生产力。政府倡议将进一步推动该领域的成长，例如印度将在2023年「印度製造」计画下开发蓝舌病夹心ELISA试剂套件和日本脑炎IgM ELISA试剂盒。

区域洞察

到2024年，北美将占据38%的市场份额，这得益于先进的兽医基础设施、高宠物拥有率（到2025年，美国将有9,400万个家庭拥有宠物）以及巨额的医疗费用支出。预计亚太地区将成长最快，这得益于人们对通用感染疾病的认识不断提高、宠物拥有率不断上升以及政府对动物健康的支持，尤其是在印度和中国等国家。

市场挑战

挑战包括先进诊断检测的高成本以及新兴市场熟练兽医的短缺，这可能会限制其应用。此外，恶劣的环境加剧了疾病的传播，因此需要持续投资于诊断和基础设施。

结论

预计到2028年，动物感染疾病诊断市场将迎来强劲成长，这得益于感染疾病盛行率的上升，尤其是通用和家畜感染疾病，以及分子诊断和照护现场诊断技术的进步。硕腾和Prosolit等主要企业的技术创新，以及对牲畜健康管理需求的不断增长，是关键的催化剂。北美和亚太地区引领着区域成长，但必须策略性地应对成本和技术短缺等挑战，才能保持市场动能。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来提供策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 全球动物感染疾病诊断市场（依技术类型）

  • 介绍
  • 免疫诊断
  • 分子诊断
  • 血液学
  • 尿液检查
  • 其他的

第六章全球动物感染疾病诊断市场（依病原体类型）

  • 介绍
  • 病毒
  • 细菌
  • 寄生虫
  • 其他的

7. 全球动物感染疾病诊断市场（依动物类型）

  • 介绍
  • 伴侣动物
    • 猫
    • 狗
    • 马
    • 其他的
  • 家畜
    • 牛
    • 猪
    • 羊
    • 其他的

第八章全球动物感染疾病诊断市场（依最终用户）

  • 介绍
  • 诊断实验室
  • 兽医诊所
  • 研究中心

9. 全球动物感染疾病诊断市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • BIOMERIEUX SA
  • Chembio Diagnostics, Inc.
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Neogen Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Virbac
  • Zoetis Inc.

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613490

The Global Veterinary Infectious Diseases Diagnostics Market is expected to grow from USD 2.795 billion in 2025 to USD 4.124 billion in 2030, at a CAGR of 8.09%.

Rising Prevalence of Infectious Diseases

The growing incidence of infectious diseases in both companion and livestock animals is a primary driver of market expansion. Zoonotic diseases, including rabies, which causes tens of thousands of deaths annually (with 99% of human cases linked to dogs, per WHO), and canine distemper, are increasing due to bacterial, viral, and parasitic infections exacerbated by poor hygiene practices in animal environments. For instance, rabies, prevalent in over 150 countries, imposes an economic burden of approximately US$8.6 billion annually, with significant impacts in Asia and Africa. Livestock animals face high disease susceptibility, with one in five farm animals lost to serious infections, leading to global economic losses of around US$80 billion. This underscores the critical need for regular diagnostic checkups to ensure animal health and prevent disease transmission, particularly for zoonotic diseases that pose public health risks. The urgency for early detection is further amplified by diseases like avian influenza, with over 3,500 outbreaks reported globally in 2023, highlighting the need for robust diagnostics.

Growing Demand for Livestock Health

Livestock animals are vital for food security, nutrition, and economic growth, yet infectious diseases threaten their productivity and the quality of animal-derived products like meat, poultry, and dairy. Unhygienic conditions, such as contaminated water sources and feed, foster the growth of bacteria and parasites, increasing disease prevalence. This drives demand for veterinary diagnostics to mitigate risks and ensure the health of livestock, which is critical for sustaining agricultural economies and meeting global food demands.

Technological Advancements

Advancements in diagnostic technologies are transforming the market by enabling faster, more accurate disease detection. In September 2024, Zoetis launched Vetscan OptiCell, an AI-powered, cartridge-based hematology analyzer for point-of-care complete blood count (CBC) analysis, offering lab-quality results with enhanced efficiency. Additionally, Zoetis introduced the Stablelab handheld device, a point-of-care blood test that detects equine inflammation via Serum Amyloid A (SAA) levels within 10 minutes, allowing veterinarians to identify infections before symptoms appear. Prosolit's ELISA kit for serodiagnosis of Bovine Adenovirus 3 provides rapid, reliable testing for cattle, targeting blood sera, plasma, and milk, enhancing diagnostic accuracy for livestock. In February 2024, MiDOG Animal Diagnostics introduced an All-in-One Diagnostic Test for rapid detection of bacterial and fungal infections, including antibiotic resistance, across various animal species, replacing traditional methods with molecular-based diagnostics. These innovations reflect a trend toward point-of-care and molecular diagnostics, improving treatment outcomes and driving market growth.

Market Segmentation Analysis

Molecular Diagnostics

The molecular diagnostics segment is poised for significant growth due to its high sensitivity, rapid results, and increasing adoption in research centers and diagnostic laboratories. Techniques like real-time PCR and multiplex PCR, as seen in products like Zoetis' VetScan Flex4, enable precise detection of genomic variants for infectious diseases, genetic disorders, and therapy monitoring. The complexity and rising prevalence of diseases in livestock and companion animals are encouraging owners to opt for these advanced tests, boosting their market share over the forecast period.

Livestock Animals

The livestock segment is expected to hold a notable market share, driven by the high disease burden and economic implications of infections. The need for routine diagnostics to monitor diseases like bovine tuberculosis, swine fever, and avian influenza is critical for maintaining herd health and ensuring food safety. For instance, regular mastitis screening in dairy cattle, supported by Zoetis' Vetscan Mastigram+ launched in August 2023, enhances milk quality and herd productivity. The segment's growth is further fueled by government initiatives, such as India's development of Bluetongue Sandwich ELISA and Japanese Encephalitis IgM ELISA kits under the "Make in India" program in 2023.

Regional Insights

North America dominates the market with a 38% share in 2024, driven by advanced veterinary infrastructure, high pet ownership (94 million U.S. households with pets in 2025), and significant health expenditure. The Asia-Pacific region is the fastest-growing, propelled by rising zoonotic disease awareness, increasing pet adoption, and government support for animal health, particularly in countries like India and China.

Market Challenges

Challenges include the high cost of advanced diagnostic tests and a shortage of skilled veterinarians in emerging markets, which may limit adoption. Additionally, ensuring hygiene in livestock environments remains a hurdle, as poor conditions exacerbate disease spread, necessitating ongoing investment in diagnostics and infrastructure.

Conclusion

The veterinary infectious disease diagnostics market is set for robust growth through 2028, driven by rising disease prevalence, particularly zoonotic and livestock infections, and advancements in molecular and point-of-care diagnostics. Innovations from key players like Zoetis and Prosolit, alongside growing demand for livestock health management, are key catalysts. North America and Asia-Pacific lead regional growth, though challenges like cost and skill shortages require strategic solutions to sustain market momentum.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology Type

  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others

By Pathogen Type

  • Virus
  • Bacteria
  • Parasite
  • Others

By Animal Type

  • Companion Animal
  • Cats
  • Dogs
  • Horse
  • Others
  • Livestock
  • Cattle
  • Swine
  • Sheep
  • Others

By End-User

  • Diagnostics Laboratories
  • Veterinary Clinics
  • Research Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY TECHNOLOGY TYPE

  • 5.1. Introduction
  • 5.2. Immunodiagnostics
  • 5.3. Molecular Diagnostics
  • 5.4. Hematology
  • 5.5. Urinalysis
  • 5.6. Others

6. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY PATHOGEN TYPE

  • 6.1. Introduction
  • 6.2. Virus
  • 6.3. Bacteria
  • 6.4. Parasite
  • 6.5. Others

7. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY ANIMAL TYPE

  • 7.1. Introduction
  • 7.2. Companion Animal
    • 7.2.1. Cats
    • 7.2.2. Dogs
    • 7.2.3. Horse
    • 7.2.4. Others
  • 7.3. Livestock
    • 7.3.1. Cattle
    • 7.3.2. Swine
    • 7.3.3. Sheep
    • 7.3.4. Others

8. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Diagnostics Laboratories
  • 8.3. Veterinary Clinics
  • 8.4. Research Centers

9. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Australia
    • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. BIOMERIEUX S.A.
  • 11.2. Chembio Diagnostics, Inc.
  • 11.3. Heska Corporation
  • 11.4. IDEXX Laboratories, Inc.
  • 11.5. INDICAL BIOSCIENCE GmbH
  • 11.6. Neogen Corporation
  • 11.7. QIAGEN N.V.
  • 11.8. Randox Laboratories Ltd.
  • 11.9. Thermo Fisher Scientific Inc.
  • 11.10. Virbac
  • 11.11. Zoetis Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations